(0)

ViroCyt

ViroCyt is the leader in the field of rapid virus quantification. Our goal is to provide the tools that deliver meaningful improvements to mission critical processes, such as vaccine manufacturing, protein expression, antiviral development and other settings where viruses play a significant role.

 

Recent News

up
down
  • ViroCyt Appoints Greg Krueger to Lead Global Sales

    BOULDER, CO–(Marketwired – July 28, 2015) – ViroCyt, the leader in rapid virus quantification, announced today that Greg Krueger has joined the team as Vice President of Global Sales. Greg brings over 20 years of experience in the commercialization of life science products, including sales, marketing and business development roles at Sartorius Stedim Biotech, Becton Dickinson,  Continue Reading »

    Read More arrow
  • ViroCyt Raises $4 Million in New Financing

    BOULDER, CO–(Marketwire – June, 2015) – ViroCyt, the leader in rapid virus quantification, announced today that it has secured over $4 million in private investment. The financing was led by a strategic investor with significant participation by existing shareholders.  ViroCyt will use the capital to expand its global reach by adding new distributors in key markets,  Continue Reading »

    Read More arrow
  • Virus Quantification Symposium in Boston

    We are excited to announce our upcoming event: Virus Quantification Symposium in Boston. You are cordially invited to join us for a symposium on virus quantification on Tuesday, June 9 from 1pm-6pm at the Joseph B. Martin Conference Center at the Harvard Medical School in Boston, Massachusetts. For more information, please register here: http://goo.gl/YrHJvD

    Read More arrow
  • Personal Invitation to our Webinar

    Dr. Michael Olszowy would like to personally invite you to our upcoming webinar.

    Read More arrow
  • Military Group Uses ViroCyt Technology to Accelerate Ebola Research

    March 11, 8:30 ET Military Group Uses ViroCyt® Technology to Accelerate Ebola Research BOULDER, CO–(Marketwire – March, 2015) – ViroCyt, Inc., the leader in rapid virus quantification, announced today that the United States Army Medical Research Institute of Infectious Diseases (USAMRIID) has published a scientific article in the journal Viruses titled “Evaluation of ViroCyt® Virus Counter®  Continue Reading »

    Read More arrow

Upcoming Events


Sep
28

ISBioTech 3rd Annual Fall Meeting Event Details

Oct
18

9th Vaccine and ISV Congress Event Details

Nov
9

World Vaccine Congress Europe Event Details